Inventor · disambiguated record
Anan Chuntharapai
Also filed as: CHUNTHARAPAI ANAN · LEE JAMES
38 granted patents·40 pending applications·1,170 citations·filing 1993–2025
98Inventor score
Top patents by PatentIndex Score
78 records- 0196US7087726B2Anti-interferon-α antibodiesGENENTECH INC·Filed 2002·Granted Aug 8, 2006·63 cites·39 claims
- 0296US6252050B1Method for making monoclonal antibodies and cross-reactive antibodies obtainable by the methodGENENTECH INC·Filed 1999·Granted Jun 26, 2001·149 cites·19 claims
- 0396US5440021AAntibodies to human IL-8 type B receptorFiled 1994·Granted Aug 8, 1995·292 cites·7 claims
- 0495US6369204B1Antibodies to αvβ3 integrinGENENTECH INC·Filed 2000·Granted Apr 9, 2002·37 cites·12 claims
- 0594US12312403B2Antibodies against TIM3 and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2023·Granted May 27, 2025·1 cites·17 claims
- 0694US10077306B2Antibodies against TIM3 and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Sep 18, 2018·7 cites·22 claims
- 0794US8350010B2Anti-alpha5/beta1 antibodyGENENTECH INC·Filed 2011·Granted Jan 8, 2013·25 cites·22 claims
- 0894US8071097B2Apoptotic anti-IgE antibodiesWU LAWREN·Filed 2008·Granted Dec 6, 2011·34 cites·64 claims
- 0993US10533052B2Antibodies against TIM3 and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Jan 14, 2020·4 cites·30 claims
- 1093US7314619B2Inducing apoptosis using anti-Apo-2 antibodiesGENENTECH INC·Filed 2001·Granted Jan 1, 2008·18 cites·33 claims
- 1192US5543503AAntibodies to human IL-8 type A receptorGENENTECH INC·Filed 1993·Granted Aug 6, 1996·124 cites·3 claims
- 1291US7595046B2Treatment of cancer using anti-Apo-2 antibodiesGENENTECH INC·Filed 2005·Granted Sep 29, 2009·4 cites·25 claims
- 1390US7803915B2Antibody compositions for the diagnosis and treatment of tumorGENENTECH INC·Filed 2004·Granted Sep 28, 2010·34 cites·26 claims
- 1490US5578704AAntibody to osteoclast alphavbeta3 ntegrinGENENTECH INC·Filed 1993·Granted Nov 26, 1996·59 cites·5 claims
- 1588US7910707B2Anti-interferon-α antibodiesGENENTECH INC·Filed 2006·Granted Mar 22, 2011·6 cites·20 claims
- 1688US7737259B2Compositions and methods for the treatment of diseases and disorders associated with cytokine signalingGENENTECH INC·Filed 2006·Granted Jun 15, 2010·14 cites·25 claims
- 1788US6046048AApo-2 ligandGENENTECH INC·Filed 1997·Granted Apr 4, 2000·57 cites·16 claims
- 1887US7592439B2Method for making monoclonal antibodies and cross-reactive antibodies obtainable by the methodGENENTECH INC·Filed 2007·Granted Sep 22, 2009·5 cites·3 claims
- 1987US2024209083A1Antibodies against tim3 and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2023·Application pending·0 cites
- 2086US11591392B2Antibodies against TIM3 and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Feb 28, 2023·1 cites·19 claims
- 2184US8586040B2Methods of using apoptotic anti-IGE antibodiesWU LAWREN·Filed 2011·Granted Nov 19, 2013·6 cites·50 claims
- 2284US8349331B2Anti-interferon-α antibodiesGENENTECH INC·Filed 2011·Granted Jan 8, 2013·4 cites·23 claims
- 2384US7807153B2Apo-2 receptor agonist antibodiesGENENTECH INC·Filed 2003·Granted Oct 5, 2010·4 cites·52 claims
- 2483US8092799B2Antibodies to Apo-2 receptor polypeptidesADAMS CAMELLIA W·Filed 2010·Granted Jan 10, 2012·2 cites·22 claims
- 2583US7252994B2Human DR4 antibodies and uses thereofGENENTECH INC·Filed 2002·Granted Aug 7, 2007·11 cites·27 claims
- 2683US6713609B1Monoclonal antibodies to type I interferon receptorGENENTECH INC·Filed 1998·Granted Mar 30, 2004·49 cites·18 claims
- 2783US5652110AAntibodies to αvβ3 integrinGENENTECH INC·Filed 1995·Granted Jul 29, 1997·42 cites·11 claims
- 2882US8632775B2Apoptotic anti-IgE antibodiesWU LAWREN·Filed 2011·Granted Jan 21, 2014·4 cites·7 claims
- 2981US8618274B2Nucleic acid encoding apoptotic anti-IgE antibodiesWU LAWREN·Filed 2011·Granted Dec 31, 2013·4 cites·35 claims
- 3078US6359126B1Antibodies to αvβ3 integrinGENENTECH INC·Filed 1997·Granted Mar 19, 2002·36 cites·28 claims
- 3178US5652109AAntibodies to αvβ3 integrinGENENTECH INC·Filed 1995·Granted Jul 29, 1997·37 cites·13 claims
- 3278US2024174749A1Methods of treating cancer with antibodies against tim3BRISTOL MYERS SQUIBB CO·Filed 2023·Application pending·0 cites
- 3376US2025326841A1Antibodies against tim3 and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2025·Application pending·0 cites
- 3476US2025115664A1Antibodies against tim3 and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2024·Application pending·0 cites
- 3572US7744881B2Human DR4 antibodies and uses thereofGENENTECH INC·Filed 2007·Granted Jun 29, 2010·2 cites·36 claims
- 3671US2010136624A1Method for making monoclonal antibodies and cross-reactive antibodies obtainable by the methodGENENTECH INC·Filed 2009·Application pending·0 cites
- 3771US2011002933A1Dr4 antibodies and uses thereofASHKENAZI AVI·Filed 2009·Application pending·0 cites
- 3868US2025197494A1Methods of treating cancer with antibodies against tim3BRISTOL MYERS SQUIBB CO·Filed 2025·Application pending·0 cites
- 3966US5840856AAntibodies to a human PF4 superfamily receptorGENENTECH INC·Filed 1994·Granted Nov 24, 1998·23 cites·2 claims
- 4064US2013309236A1Anti-interferon-alpha antibodiesGENENTECH INC·Filed 2013·Application pending·0 cites
- 4163US2007015247A1Method for making monoclonal antibodies and cross-reactive antibodies obtainable by the methodGENENTECH INC·Filed 2006·Application pending·0 cites
- 4262US12129297B2Antibodies against TIM3 and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Oct 29, 2024·0 cites·10 claims
- 4362US2023052312A1Anti-pd-l1 antibodies and methods of using the same for detection of pd-l1GENENTECH INC·Filed 2022·Application pending·0 cites
- 4462US2010273257A1Apo-2DcRGENENTECH INC·Filed 2009·Application pending·0 cites
- 4562US2013084295A1Anti-interferon-alpha antibodiesGENENTECH INC·Filed 2012·Application pending·0 cites
- 4661US2014115729A1Apoptotic anti-ige antibodiesGENENTECH INC·Filed 2013·Application pending·0 cites
- 4761US2021363242A1Methods of treating cancer with antibodies against tim3BRISTOL MYERS SQUIBB CO·Filed 2019·Application pending·0 cites
- 4861US2004120947A1DR4 antibodies and uses thereofGENENTECH INC·Filed 2003·Application pending·0 cites
- 4960US2005282230A1Method for making monoclonal antibodies and cross-reactive antibodies obtainable by the methodGENENTECH INC·Filed 2005·Application pending·0 cites
- 5060US2006020118A1Monoclonal antibodies to type I interferon receptorGENENTECH INC·Filed 2004·Application pending·0 cites
Showing the top 50 of 78 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Anan Chuntharapai files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →